Adjunctive effects of eltrombopag on immunosuppressive therapy for childhood aplastic anemia

Young NS. Aplastic anemia. N Engl J Med. 2018;379:1643–56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Furlong E, Carter T. Aplastic anaemia: current concepts in diagnosis and management. J Paediatr Child Health. 2020;56:1023–8.

Article  PubMed  Google Scholar 

Bacigalupo A. How I treat acquired aplastic anemia. Blood. 2017;129:1428–36.

Article  CAS  PubMed  Google Scholar 

Yoshida N, Kobayashi R, Yabe H, Kosaka Y, Yagasaki H, Watanabe K, et al. First-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapy. Haematologica. 2014;99:1784–91.

Article  PubMed  PubMed Central  Google Scholar 

Dufour C, Veys P, Carraro E, Bhatnagar N, Pillon M, Wynn R, et al. Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK paediatric BMT working party, paediatric diseases working party and severe aplastic anaemia working party of EBMT. Br J Haematol. 2015;171:585–94.

Article  CAS  PubMed  Google Scholar 

Ohara A, Kojima S, Hamajima N, Tsuchida M, Imashuku S, Ohta S, et al. Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia. Blood. 1997;90:1009–13.

Article  CAS  PubMed  Google Scholar 

Socie G, Henry-Amar M, Bacigalupo A, Hows J, Tichelli A, Ljungman P, et al. Malignant tumors occurring after treatment of aplastic anemia. European bone marrow transplantation-severe aplastic anaemia working party. N Engl J Med. 1993;329:1152–7.

Article  CAS  PubMed  Google Scholar 

Yoshida N, Yagasaki H, Hama A, Takahashi Y, Kosaka Y, Kobayashi R, et al. Predicting response to immunosuppressive therapy in childhood aplastic anemia. Haematologica. 2011;96:771–4.

Article  PubMed  PubMed Central  Google Scholar 

Narita A, Zhu X, Muramatsu H, Chen X, Guo Y, Yang W, et al. Prospective randomized trial comparing two doses of rabbit anti-thymocyte globulin in patients with severe aplastic anaemia. Br J Haematol. 2019;187:227–37.

Article  CAS  PubMed  Google Scholar 

Cui L, Moraga I, Lerbs T, Van Neste C, Wilmes S, Tsutsumi N, et al. Tuning MPL signaling to influence hematopoietic stem cell differentiation and inhibit essential thrombocythemia progenitors. Proc Natl Acad Sci U S A. 2021;118: e2017849118.

Article  CAS  PubMed  Google Scholar 

Desmond R, Townsley DM, Dumitriu B, Olnes MJ, Scheinberg P, Bevans M, et al. Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug. Blood. 2014;123:1818–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peffault de Latour R, Kulasekararaj A, Iacobelli S, Terwel SR, Cook R, Griffin M, et al. Eltrombopag added to immunosuppression in severe aplastic anemia. N Engl J Med. 2022;386:11–23.

Article  CAS  PubMed  Google Scholar 

Yamazaki H, Ohta K, Iida H, Imada K, Obara N, Tokumine Y, et al. Hematologic recovery induced by eltrombopag in Japanese patients with aplastic anemia refractory or intolerant to immunosuppressive therapy. Int J Hematol. 2019;110:187–96.

Article  CAS  PubMed  Google Scholar 

Imada K, Obara N, Iida H, Imajo K, Maeda T, Usuki K, et al. Eltrombopag in combination with rabbit anti-thymocyte globulin/cyclosporine a in immunosuppressive therapy-naïve patients with aplastic anemia in Japan. Intern Med. 2021;60:1159–68.

Article  CAS  PubMed  Google Scholar 

Marrapodi MM, Mascolo A, Roberti D, Martino MD, Rafaniello C, Riccardi C, et al. The efficacy and the safety of eltrombopag in pediatric patients with severe aplastic anemia: a systematic review. Front Pediatr. 2023;11:1149718.

Article  PubMed  PubMed Central  Google Scholar 

Groarke EM, Patel BA, Gutierrez-Rodrigues F, Rios O, Lotter J, Baldoni D, et al. Eltrombopag added to immunosuppression for children with treatment-naïve severe aplastic anaemia. Br J Haematol. 2021;192:605–14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fang M, Song H, Zhang J, Li S, Shen D, Tang Y. Efficacy and safety of immunosuppressive therapy with or without eltrombopag in pediatric patients with acquired aplastic anemia: a Chinese retrospective study. Pediatr Hematol Oncol. 2021;38:633–46.

Article  CAS  PubMed  Google Scholar 

Lesmana H, Jacobs T, Boals M, Gray N, Lewis S, Ding J, et al. Eltrombopag in children with severe aplastic anemia. Pediatr Blood Cancer. 2021;68: e29066.

Article  CAS  PubMed  Google Scholar 

Filippidou M, Avgerinou G, Tsipou H, Tourkantoni N, Katsibardi K, Vlachou A, et al. Longitudinal evaluation of eltrombopag in paediatric acquired severe aplastic anaemia. Br J Haematol. 2020;190:e157–9.

Article  PubMed  Google Scholar 

Goronkova O, Novichkova G, Salimova T, Kalinina I, Baidildina D, Petrova U, et al. Efficacy of combined immunosuppression with or without eltrombopag in children with newly diagnosed aplastic anemia. Blood Adv. 2023;7:953–62.

Article  CAS  PubMed  Google Scholar 

Fan X, Desmond R, Winkler T, Young DJ, Dumitriu B, Townsley DM, et al. Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias. Blood Adv. 2020;4:1700–10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giudice V, Selleri C. Aplastic anemia: pathophysiology. Semin Hematol. 2022;59:13–20.

Article  PubMed  Google Scholar 

Patel BA, Groarke EM, Lotter J, Shalhoub R, Gutierrez-Rodrigues F, Rios O, et al. Long-term outcomes in patients with severe aplastic anemia treated with immunosuppression and eltrombopag: a phase 2 study. Blood. 2022;139:34–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Değirmenci BB, Yegin ZA, Dikyar A, Kaynar LA, Nur Özkurt Z, Göçün PU, et al. Eltrombopag may induce bone marrow fibrosis in allogeneic hematopoietic stem cell transplant recipients with prolonged thrombocytopenia. Leuk Res. 2022;118: 106870.

Article  Google Scholar 

Kubota I, Nagasawa S, Nakagawa M, Yamada A, Kinoshita M, Kamimura S, et al. Successful treatment of eltrombopag following immunosuppressive therapy in pediatric aplastic anemia. Rinsho Ketsueki. 2023;64:741–5.

PubMed  Google Scholar 

留言 (0)

沒有登入
gif